Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Izuru Ando"'
Autor:
Kunihiro Hirahara, Gabriela Turcanu, Toru Noguchi, Barbara Gerhardt, Yukiyo Toyonaga, Sudhakar M. Pai, Kan Yee, Maribel Rodriguez-Torres, Tsutomu Shibata, Naoki Ogura, Izuru Ando
Publikováno v:
Antimicrobial Agents and Chemotherapy. 57:436-444
JTK-853, a palm site-binding NS5B nonnucleoside polymerase inhibitor, shows antiviral activity in vitro and in hepatitis C virus (HCV)-infected patients. Here, we report the results of genotypic and phenotypic analyses of resistant variants in 24 HCV
Isolation and gene analysis of interferon α-resistant cell clones of the hepatitis C virus subgenome
Publikováno v:
Virology. 375:424-432
Hepatitis C virus (HCV) proteins appear to play an important role in IFN-resistance, but the molecular mechanism remains unclear. To clarify the mechanism in HCV replicon RNA harboring Huh-7 cells (Huh-9-13), we isolated cellular clones with impaired
Autor:
Yoshinori Hara, Satoru Noji, Satoru Ikeda, Hiroshi Yamanaka, Shintaro Hirashima, Kazutaka Ikegashira, Hiromasa Hashimoto, Yasushi Niwa, Ryo Mizojiri, Toru Noguchi, Takahiro Oka, Izuru Ando, Hiroyuki Goto
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 17:3181-3186
Following the discovery of JTK-109 ( 1 ) as a potent inhibitor of hepatitis C virus NS5B RNA-dependent RNA polymerase, [(a) Hirashima, S.; Suzuki, T.; Ishida, T.; Noji, S.; Yata, S.; Ando, I.; Komatsu, M.; Ikeda, S.; Hashimoto, H. J. Med. Chem. 2006
Autor:
Satoru Ikeda, Hiromasa Hashimoto, Shintaro Hirashima, Tomio Ishida, Izuru Ando, Takayoshi Suzuki, Atsuhito Yoshida, Tsuyoshi Adachi, Mizutani Kenji
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 16:1859-1863
A series of 1-cycloalkyl-2-phenyl-1H-benzimidazole-5-carboxylic acid derivatives was synthesized and evaluated for inhibitory activity against HCV NS5B RNA-dependent RNA polymerase (RdRp). A SAR study was performed and led to identify the 2-[(4-diary
Autor:
Izuru, Ando
Publikováno v:
グローカル. :13-21
Autor:
Takao Kataoka, Kazuo Nagai, Sachiko Akashi, Tetsuya Wakabayashi, Izuru Ando, Yoshinori Tsukumo, Kensuke Miyake
Publikováno v:
International Immunopharmacology. 2:1155-1162
Two active polysaccharide fractions (SF1 and SF2) purified from dried safflower petals (Carthamus tinctorius L.) stimulated the synthesis of various cytokines by peritoneal macrophages. In a number of cell types, SF1 and SF2 induced a rapid degradati
Publikováno v:
Intervirology. 56(5)
JTK-853 is a novel, non-nucleoside, palm site-binding hepatitis C virus (HCV) polymerase inhibitor that has demonstrated antiviral activity in HCV-infected patients during 3 days of treatment. To estimate the genetic barrier of JTK-853 to resistance
Autor:
Yukiyo Toyonaga, Izuru Ando, Kazuyuki Sugimoto, Masafumi Kamada, Toru Noguchi, Naoki Ogura, Tsuyoshi Adachi, Hiroyuki Abe
JTK-853 is a novel piperazine derivative nonnucleoside inhibitor of hepatitis C virus (HCV) RNA-dependent RNA polymerase. JTK-853 showed potent inhibitory activity against genotype 1 HCV polymerase, with a 50% inhibitory concentration in the nanomola
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9431b46c20e91f50108fa00d9e53c3fe
https://europepmc.org/articles/PMC3421577/
https://europepmc.org/articles/PMC3421577/
Autor:
Tsuyoshi Adachi, Yoshinori Hara, Naoki Ogura, Shintaro Hirashima, Hiromasa Hashimoto, Tsuruha Junichiro, Kazutaka Ikegashira, Satoru Noji, Hiroshi Yamanaka, Toru Noguchi, Satoru Ikeda, Satoki Doi, Yasunori Hase, Izuru Ando, Takahiro Oka
Publikováno v:
Journal of medicinal chemistry. 49(24)
We report a new series of hepatitis C virus NS5B RNA polymerase inhibitors containing a conformationally constrained tetracyclic scaffold. SAR studies led to the identification of 6,7-dihydro-5H-benzo[5,6][1,4]diazepino[7,1-a]indoles (19 and 20) bear
Autor:
Shintaro Hirashima, Tomio Ishida, Izuru Ando, Takayoshi Suzuki, Satoru Ikeda, Shinji Yata, Masakazu Komatsu, Satoru Noji, Hiromasa Hashimoto
Publikováno v:
Journal of medicinal chemistry. 49(15)
Following the discovery of a new series of benzimidazole derivatives bearing a diarylmethyl group as inhibitors of hepatitis C virus NS5B RNA-dependent RNA polymerase (HCV NS5B RdRp),1,2 we extended the structure-activity relationship (SAR) study to